Johannes Siegrist Selected Research

Johannes Siegrist Research Topics

9	Occupational Stress 12/2022 - 05/2004
4	Inflammation (Inflammations) 11/2017 - 09/2006
4	Coronary Artery Disease (Coronary Atherosclerosis) 03/2011 - 08/2002
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2013 - 08/2002
2	Obesity 01/2018 - 01/2013
2	Hypertension (High Blood Pressure) 01/2018 - 01/2006
2	Atherosclerosis 04/2008 - 09/2007
1	Opioid-Related Disorders (Opiate Addiction) 12/2021
1	Drug Misuse 12/2021
1	Chronic Disease (Chronic Diseases) 01/2020
1	Coronary Disease (Coronary Heart Disease) 11/2017
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2017
1	Prediabetic State (Prediabetes) 12/2013
1	Mobility Limitation (Difficulty Walking) 01/2013
1	Cognitive Dysfunction 01/2012
1	Mental Disorders (Mental Disorder) 08/2007
1	Fatigue 06/2005
1	Lipodystrophy 09/2002
1	Death (Near-Death Experience) 08/2002
1	Myocardial Infarction 08/2002
1	Musculoskeletal Pain 01/2002

5	Hydrocortisone (Cortisol)FDA LinkGeneric 11/2019 - 05/2004
3	LipidsIBA 11/2017 - 01/2006
3	C-Reactive ProteinIBA 01/2012 - 04/2008
2	CalciumIBA 09/2007 - 08/2002
1	3,4-methylenedioxyethamphetamine (MDEA)IBA 12/2022
1	Hypnotics and Sedatives (Sedatives)IBA 12/2021
1	CholesterolIBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 11/2017
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 12/2013
1	Glucose (Dextrose)FDA LinkGeneric 12/2013
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2011
1	Dexamethasone (Maxidex)FDA LinkGeneric 05/2010
1	Petroleum (Crude Oil)IBA 08/2007
1	TroponinIBA 09/2006
1	Psychotropic Drugs (Psychoactive Drugs)IBA 06/2005

1	Vocational Rehabilitation 01/2020
1	Activities of Daily Living (ADL) 01/2013
1	Therapeutics 03/2011
1	Highly Active Antiretroviral Therapy (HAART) 09/2002
1	Secondary Prevention 01/2002